RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutics...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced the company will present modeling data evaluati...
Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into ...
PacBio , a leading developer of high-quality, highly accurate sequencing solutions, announced the signing of a new Research Collaboration Agre...
Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage oncology company pioneering the development of site-specific and novel-format antibody-drug conjug...
Simultaneously and reliably quantify proteins, including post-translational modifications (PTMs), in a single-cell RNA sequencing (RNA-seq) assay using...
The Nobel Prize in Physiology or Medicine has been awarded to American researchers Victor Ambros and Gary Ruvkun for their pioneering discovery of microR...
Singular Genomics Systems, a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and cli...
New technologies will contribute to performing genetic tests to diagnose cancers, rare diseases and other diseases with greater precision, advancing pers...
Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China wil...
Clore and Ottensmann explain: Synthetic biology is revolutionizing medical treatments for a wide range of diseases. It’s what made it possib...
China’s National Intellectual Property Administration has issued notification to grant patent to PolTREG Chinese patent covers intrathecal...
Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral disea...
Oneness Biotech and Microbio (Shanghai) announced that the pan-COVID New Drug, SNS812, co-developed by both companies achieves statistical significance wit...
© 2025 Biopharma Boardroom. All Rights Reserved.
